The DOI matches its Crossref record; 334 of the 334 references it cites were found in a registry or an index.
Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
Open accessAbstract
Neurodegenerative diseases are a common cause of morbidity and cognitive impairment in older adults. Most clinicians who care for the elderly are not trained to diagnose these conditions, perhaps other than typical Alzheimer's disease (AD). Each of these disorders has varied epidemiology, clinical symptomatology, laboratory and neuroimaging features, neuropathology, and management. Thus, it is important that clinicians be able to differentiate and diagnose these conditions accurately. This review summarizes and highlights clinical aspects of several of the most commonly encountered neurodegenerative diseases, including AD, frontotemporal dementia (FTD) and its variants, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), Parkinson's disease (PD), dementia with Lewy bodies (DLB), multiple system atrophy (MSA), and Huntington's disease (HD). For each condition, we provide a brief overview of the epidemiology, defining clinical symptoms and diagnostic criteria, relevant imaging and laboratory features, genetics, pathology, treatments, and differential diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–334 of 334
Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease
Drzezga, A., Grimmer, T., Henriksen, G., Mühlau, M., Perneczky, R., Miederer, I., Praus, C., Sorg, C., Wohlschläger, A., Riemenschneider, M., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a2e8d0 · Cited by 248
Risk of Parkinson's disease among first-degree relatives: A community-based study
Marder, K., Tang, M.-X., Mejia, H., Alfaro, B., Cote, L., Louis, E., Groves, J., & Mayeux, R. (1996) · Neurology · doi:10.1212/wnl.47.1.155 · Cited by 248
Stankovic, I., Krismer, F., Jesic, A., Antonini, A., Benke, T., Brown, R. G., Burn, D. J., Holton, J. L., Kaufmann, H., Kostic, V. S., et al. (2014) · Movement Disorders · doi:10.1002/mds.25880 · Cited by 248
Red flags for multiple system atrophy
Köllensperger, M., Geser, F., Seppi, K., Stampfer‐Kountchev, M., Sawires, M., Scherfler, C., Boesch, S., Mueller, J., Koukouni, V., Quinn, N., et al. (2008) · Movement Disorders · doi:10.1002/mds.21992 · Cited by 244
Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis
Moisan, F., Kab, S., Mohamed, F., Canonico, M., Le Guern, M., Quintin, C., Carcaillon, L., Nicolau, J., Duport, N., Singh-Manoux, A., et al. (2016) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-312283 · Cited by 244
Estimating the Number of Persons with Frontotemporal Lobar Degeneration in the US Population
Knopman, D. S., & Roberts, R. O. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9538-y · Cited by 236
Voxel-based morphometry in autopsy proven PSP and CBD
Josephs, K. A., Whitwell, J. L., Dickson, D. W., Boeve, B. F., Knopman, D. S., Petersen, R. C., Parisi, J. E., & Jack, C. R. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.019 · Cited by 234
Classification and pathology of primary progressive aphasia
Harris, J. M., Gall, C., Thompson, J. C., Richardson, A. M. T., Neary, D., du Plessis, D., Pal, P., Mann, D. M. A., Snowden, J. S., & Jones, M. (2013) · Neurology · doi:10.1212/01.wnl.0000436070.28137.7b · Cited by 232
Paulsen, J. S., Long, J. D., Ross, C. A., Harrington, D. L., Erwin, C. J., Williams, J. K., Westervelt, H. J., Johnson, H. J., Aylward, E. H., Zhang, Y., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70238-8 · Cited by 227
Age‐specific progression of nigrostriatal dysfunction in Parkinson's disease
de la Fuente‐Fernández, R., Schulzer, M., Kuramoto, L., Cragg, J., Ramachandiran, N., Au, W. L., Mak, E., McKenzie, J., McCormick, S., Sossi, V., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22284 · Cited by 222
Psychiatric disorders in preclinical Huntington's disease
Julien, C. L., Thompson, J. C., Wild, S., Yardumian, P., Snowden, J. S., Turner, G., & Craufurd, D. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.103309 · Cited by 219
Grossman, M., Mickanin, J., Onishi, K., Hughes, E., D'Esposito, M., Ding, X.-S., Alavi, A., & Reivich, M. (1996) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.1996.8.2.135 · Cited by 216
Diagnostic criteria for Huntington's disease based on natural history
Reilmann, R., Leavitt, B. R., & Ross, C. A. (2014) · Movement Disorders · doi:10.1002/mds.26011 · Cited by 214
In vivo amyloid imaging with PET in frontotemporal dementia
Engler, H., Santillo, A. F., Wang, S. X., Lindau, M., Savitcheva, I., Nordberg, A., Lannfelt, L., Långström, B., & Kilander, L. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0523-1 · Cited by 214
Dementia with Lewy bodies and Alzheimer disease: Neurodegenerative patterns characterized by DTI
Kantarci, K., Avula, R., Senjem, M. L., Samikoglu, A. R., Zhang, B., Weigand, S. D., Przybelski, S. A., Edmonson, H. A., Vemuri, P., Knopman, D. S., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e0f7cf · Cited by 213
Longitudinal Evaluation of Neuropsychiatric Symptoms in Huntington's Disease
Thompson, J. C., Harris, J., Sollom, A. C., Stopford, C. L., Howard, E., Snowden, J. S., & Craufurd, D. (2012) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.11030057 · Cited by 211
Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY
Orth, M., Handley, O. J., Schwenke, C., Dunnett, S. B., Craufurd, D., Ho, A. K., Wild, E., Tabrizi, S. J., & Landwehrmeyer, G. B. (2011) · PLoS Currents · doi:10.1371/currents.rrn1184 · Cited by 208
Van Duijn, C. M., Clayton, D., Chandra, V, Fratiglioni, L., Graves, A. B., Heyman, A., Jorm, A. F., Kokmen, E., Kondo, K., Mortimer, J. A., et al. (1991) · International Journal of Epidemiology · doi:10.1093/ije/20.supplement_2.s13 · Cited by 206
Evolving basic, pathological and clinical concepts in PD
Kalia, L. V., & Lang, A. E. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.249 · Cited by 206
Accuracy of the Clinical Evaluation for Frontotemporal Dementia
Mendez, M. F., Shapira, J. S., McMurtray, A., Licht, E., & Miller, B. L. (2007) · Archives of Neurology · doi:10.1001/archneur.64.6.830 · Cited by 205
APOE alleles predict the rate of cognitive decline in Alzheimer disease: A nonlinear model
Martins, C. A. R., Oulhaj, A., de Jager, C. A., & Williams, J. H. (2005) · Neurology · doi:10.1212/01.wnl.0000188871.74093.12 · Cited by 205
Ishii, K., Kawachi, T., Sasaki, H., Kono, A. K., Fukuda, T., KOJIMA, Y., & Mori, E. (2005) · PubMed · Cited by 193
Incidence of early-onset dementias in Cambridgeshire, United Kingdom
Mercy, L., Hodges, J. R., Dawson, K., Barker, R. A., & Brayne, C. (2008) · Neurology · doi:10.1212/01.wnl.0000334277.16896.fa · Cited by 189
Khan, B. K., Yokoyama, J. S., Takada, L. T., Sha, S. J., Rutherford, N. J., Fong, J. C., Karydas, A. M., Wu, T., Ketelle, R. S., Baker, M. C., et al. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301883 · Cited by 185
Velakoulis, D., Walterfang, M., Mocellin, R., Pantelis, C., & McLean, C. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.057034 · Cited by 180
Armstrong, M. J., & Miyasaki, J. M. (2012) · Neurology · doi:10.1212/wnl.0b013e318263c443 · Cited by 180
Galantamine for Alzheimer's disease
Loy, C., & Schneider, L. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001747.pub2 · Cited by 178
Metabolic network abnormalities in early Huntington's disease: an [(18)F]FDG PET study.
Feigin, A., Leenders, K. L., Moeller, J. R., Missimer, J. H., Kuenig, G., Spetsieris, P. G., Antonini, A., & Eidelberg, D. (2001) · PubMed · Cited by 178
Frontal presentation in progressive supranuclear palsy
Kaat, L. D., Boon, A. J. W., Kamphorst, W., Ravid, R., Duivenvoorden, H. J., & van Swieten, J. C. (2007) · Neurology · doi:10.1212/01.wnl.0000267643.24870.26 · Cited by 175
Samuel, W., Caligiuri, M., Galasko, D., Lacro, J., Marini, M., McClure, F. S., Warren, K., & Jeste, D. V. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/1099-1166(200009)15:9<794::aid-gps178>3.0.co;2-1 · Cited by 174
Cortical and striatal neurone number in Huntington's disease
Heinsen, H., Strik, M., Bauer, M., Luther, K., Ulmar, G., Gangnus, D., Jungkunz, G., Eisenmengers, W., & G�tz, M. (1994) · Acta Neuropathologica · doi:10.1007/bf00310376 · Cited by 174
Multisource ascertainment of Huntington disease in Canada: Prevalence and population at risk
Fisher, E. R., & Hayden, M. R. (2014) · Movement Disorders · doi:10.1002/mds.25717 · Cited by 173
Risk factors for dementia with Lewy bodies: A case-control study
Boot, B. P., Orr, C. F., Ahlskog, J. E., Ferman, T. J., Roberts, R., Pankratz, V. S., Dickson, D. W., Parisi, J., Aakre, J. A., Geda, Y. E., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a2cbd1 · Cited by 173
Frontotemporal Dementia: Paroxetine as a Possible Treatment of Behavior Symptoms
Moretti, R., Torre, P., Antonello, R. M., Cazzato, G., & Bava, A. (2003) · European Neurology · doi:10.1159/000067021 · Cited by 172
Capgras Syndrome and Its Relationship to Neurodegenerative Disease
Josephs, K. A. (2007) · Archives of Neurology · doi:10.1001/archneur.64.12.1762 · Cited by 169
Brain amyloid and cognition in Lewy body diseases
Gomperts, S. N., Locascio, J. J., Marquie, M., Santarlasci, A. L., Rentz, D. M., Maye, J., Johnson, K. A., & Growdon, J. H. (2012) · Movement Disorders · doi:10.1002/mds.25048 · Cited by 168
Proposed neuroimaging criteria for the diagnosis of multiple system atrophy
Brooks, D. J., Seppi, K., & for the Neuroimaging Working Group on MSA (2009) · Movement Disorders · doi:10.1002/mds.22413 · Cited by 166
Gasser, T., Hardy, J., & Mizuno, Y. (2011) · Movement Disorders · doi:10.1002/mds.23637 · Cited by 166
Anterior insula degeneration in frontotemporal dementia
Seeley, W. W. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0263-z · Cited by 162
Mutations in the TIGR Gene in Familial Primary Open-Angle Glaucoma in Japan
Suzuki, Y., Shirato, S., Taniguchi, F., Ohara, K., Nishimaki, K., & Ohta, S. (1997) · The American Journal of Human Genetics · doi:10.1086/301612 · Cited by 161
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY
Orth, M., & The European Huntington 's Disease Network (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.209668 · Cited by 161
A genome-wide association study in multiple system atrophy
Sailer, A., Scholz, S. W., Nalls, M. A., Schulte, C., Federoff, M., Price, T. R., Lees, A., Ross, O. A., Dickson, D. W., Mok, K., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003221 · Cited by 160
Burn, D. J., Rowan, E. N., Minett, T., Sanders, J., Myint, P., Richardson, J., Thomas, A., Newby, J., Reid, J., O'Brien, J. T., et al. (2003) · Movement Disorders · doi:10.1002/mds.10455 · Cited by 159
Benefits of rivastigmine on attention in dementia associated with Parkinson disease
Wesnes, K. A., McKeith, I., Edgar, C., Emre, M., & Lane, R. (2005) · Neurology · doi:10.1212/01.wnl.0000184517.69816.e9 · Cited by 159
Premotor signs and symptoms of multiple system atrophy
Ječmenica‐Lukić, M., Poewe, W. H., TOLOSA, E. S., & Wenning, G. K. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70022-4 · Cited by 157
Wolk, D. A. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.153 · Cited by 156
The behavioural variant frontotemporal dementia (bvFTD) syndrome in psychiatry
Lanata, S., & Miller, B. L. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310697 · Cited by 155
Clinical features and autonomic testing predict survival in multiple system atrophy
Coon, E. A., Sletten, D. M., Suarez, M. D., Mandrekar, J. N., Ahlskog, J. E., Bower, J. H., Matsumoto, J. Y., Silber, M. H., Benarroch, E. E., Fealey, R. D., et al. (2015) · Brain · doi:10.1093/brain/awv274 · Cited by 154
Rüb, U., Hoche, F., Brunt, E. R. P., Heinsen, H., Seidel, K., Turco, D. D., Paulson, H. L., Böhl, J., von Gall, C., Vonsattel, J., et al. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00629.x · Cited by 150
Neurobehavioral Features in Frontotemporal Dementia With Amyotrophic Lateral Sclerosis
Lillo, P., Garcin, B., Hornberger, M., Bak, T. H., & Hodges, J. R. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.146 · Cited by 148
The association of CAG repeat length with clinical progression in Huntington disease
Rosenblatt, A., Liang, K.-Y., Zhou, H., Abbott, M. H., Gourley, L. M., Margolis, R. L., Brandt, J., & Ross, C. A. (2006) · Neurology · doi:10.1212/01.wnl.0000204230.16619.d9 · Cited by 146
Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease
Chen‐Plotkin, A. S., Hu, W. T., Siderowf, A. D., Weintraub, D. A., Gross, R. G., Hurtig, H. I., Xie, S. X., Arnold, S. E., Grossman, M., Clark, C. M., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22271 · Cited by 142
Suicide risk in Huntington's disease.
Maio, L. D., Squitieri, F., Napolitano, G., Campanella, G., Trofatter, J. A., & Conneally, P. M. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.4.293 · Cited by 140
Randomized controlled trial of memantine in dementia associated with Parkinson's disease
Leroi, I., Overshott, R., Byrne, E. J., Daniel, E., & Burns, A. S. (2009) · Movement Disorders · doi:10.1002/mds.22495 · Cited by 140
Schrag, A. E., Sheikh, S., Quinn, N. P., Lees, A. J., Selai, C. E., Mathias, C. J., Litvan, I., Lang, A. E., Bower, J. H., Burn, D. J., et al. (2010) · Movement Disorders · doi:10.1002/mds.22794 · Cited by 140
Markowitsch, H. J., & Staniloiu, A. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61304-4 · Cited by 140
Ewers, M., Mattsson, N., Minthon, L., Molinuevo, J. L., Antonell, A., Popp, J., Jessen, F., Herukka, S., Soininen, H., Maetzler, W., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.12.006 · Cited by 139
Herrmann, N., Black, S. E., Chow, T. W., Cappell, J., Tang‐Wai, D. F., & Lanctôt, K. L. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31823033f3 · Cited by 136
Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia
Gefen, T. D., Gasho, K., RADEMAKER, A. W., Lalehzari, M., Weıntraub, S., Rogalski, E. J., Wieneke, C., Bigio, E. H., Geula, C., & Mesulam, M. M. (2012) · Brain · doi:10.1093/brain/aws076 · Cited by 135
Clinical Features of Alzheimer Disease With and Without Lewy Bodies
Chung, E. J., Babulal, G. M., Monsell, S. E., Cairns, N. J., Roe, C. M., & Morris, J. C. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0606 · Cited by 134
FDG PET and MRI in Logopenic Primary Progressive Aphasia versus Dementia of the Alzheimer’s Type
Madhavan, A. A., Whitwell, J. L., Weigand, S. D., Duffy, J. R., Strand, E. A., Machulda, M. M., Tosakulwong, N., Senjem, M. L., Gunter, J. L., Lowe, V. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062471 · Cited by 130
Atrophy of superior cerebellar peduncle in progressive supranuclear palsy
Tsuboi, Y., Slowinski, J. L., Josephs, K. A., Honer, W. G., Wszołek, Z. K., & Dickson, D. W. (2003) · Neurology · doi:10.1212/01.wnl.0000068011.21396.f4 · Cited by 130
Late onset of Huntington's disease.
Myers, R. H., Sax, D. S., Schoenfeld, M., Bird, E. D., Wolf, P. A., Vonsattel, J. P., White, R. F., & Martin, J. B. (1985) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.6.530 · Cited by 127
“Applause sign” helps to discriminate PSP from FTD and PD
Dubois, B., Slachevsky, A., Pillon, B., Beato, R., Villalponda, J. M., & Litvan, I. (2005) · Neurology · doi:10.1212/01.wnl.0000165977.38272.15 · Cited by 127
Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · cited 1×
“Combining acetylcholinesterase inhibition and memantine may have a marginal benefit compared with treatment with a single drug, although improved functional outcomes have not been shown (Farrimond et al. 2012).”
BackgroundGeser, F., Wenning, G., Seppi, K., Stampfer-Kountchev, M., Scherfler, C., Sawires, M., Frick, C., Ndayisaba, J., Ulmer, H., Pellecchia, M. T., et al. (2006) · Movement Disorders · doi:10.1002/mds.20678 · Cited by 122
The many faces of corticobasal degeneration
Wadia, P. M., & Lang, A. E. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70027-0 · Cited by 120
Psychopathology in Huntington's disease patients
Shiwach, R. S. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01587.x · Cited by 117
Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer’s disease: An MRI study
Cousins, D. A., Burton, E. J., Burn, D. J., Gholkar, A. R., McKeith, I. G., & O'Brien, J. T. (2003) · Neurology · doi:10.1212/01.wnl.0000091889.20347.30 · Cited by 114
Changes in mental state and behaviour in Huntington's disease
Eddy, C. M., Parkinson, E. G., & Rickards, H. E. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30144-4 · Cited by 111
Clinical diagnostic criteria and classification controversies in frontotemporal lobar degeneration
Rascovsky, K., & Grossman, M. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2013.763341 · Cited by 110
Patterns of Frontal Lobe Atrophy in Frontotemporal Dementia: A Volumetric MRI Study
Perry, R. J., Graham, A., Williams, G. B., Rosen, H. J., Erzinçlioğlu, S., Weiner, M. W., Miller, B. L., & Hodges, J. R. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000095128 · Cited by 101
Cerebral Metabolic Dysfunction in Patients with Dementia with Lewy Bodies and Visual Hallucinations
Perneczky, R., Drzezga, A. E., Boecker, H., Förstl, H., Kurz, A., & Häussermann, P. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000132084 · Cited by 101
Patterns of Cerebral Atrophy in Primary Progressive Aphasia
Rosen, H. J., Kramer, J. H., Gorno‐Tempini, M. L., Schuff, N. W., Weiner, M. W., & Miller, B. L. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200201000-00011 · Cited by 99
Gilman, S., Koeppe, R. A., Junck, L., Kluin, K. J., Lohman, M., & Laurent, R. T. S. (1994) · Annals of Neurology · doi:10.1002/ana.410360208 · Cited by 94
Dopamine transporter imaging in autopsy‐confirmed Parkinson's disease and multiple system atrophy
Perju‐Dumbrava, L., Kovács, G. G., Pirker, S., Jellinger, K. A., Hoffmann, M., Asenbaum, S., & Pirker, W. (2011) · Movement Disorders · doi:10.1002/mds.24000 · Cited by 94
Short-term effects of olanzapine in Huntington disease.
Squitieri, F., Cannella, M., Porcellini, A., Brusa, L., Simonelli, M., & Ruggieri, S. A. (2001) · PubMed · Cited by 93
Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E ε4 allele
Mori, E., Lee, K., Yasuda, M., Hashimoto, M., Kazui, H., Hirono, N., & Matsui, M. (2002) · Annals of Neurology · doi:10.1002/ana.10093 · Cited by 93
Cognitive impairment in motor neuron disease with bulbar onset
Portet, F., Cadilhac, C., Touchon, J., & Camu, W. (2001) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608201300079382 · Cited by 93
Farrimond, L. E., Roberts, E., & McShane, R. H. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-000917 · Cited by 92
The North American Multiple System Atrophy Study Group
Gilman, S., May, S. J., Shults, C. W., Tanner, C. M., Kukull, W. A., Lee, V. M.-Y., Masliah, E., Low, P. A., Sandroni, P., Trojanowski, J. Q., et al. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0381-6 · Cited by 89
Progressive Supranuclear Palsy with Dementia: Cortical Pathology
Bigio, E. H., Brown, D. F., & White, C. L. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199904000-00006 · Cited by 88
Sources of Variability in Prevalence Rates of Alzheimer's Disease
Corrada, M. M., Brookmeyer, R., & Kawas, C. H. (1995) · International Journal of Epidemiology · doi:10.1093/ije/24.5.1000 · Cited by 86
CLINICOPATHOLOGIC STUDY OF A SNCA GENE DUPLICATION PATIENT WITH PARKINSON DISEASE AND DEMENTIA
Obi, T., Nishioka, K., Ross, O. A., Terada, T., Yamazaki, K., Sugiura, A., Takanashi, M., Mizoguchi, K., Mori, H., Mizuno, Y., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000299387.59159.db · Cited by 85
Genetics of SynucleinopathiesPreprint
Nussbaum, R. L. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024109 · Cited by 85
CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls
Herbert, M. K., Eeftens, J. M., Aerts, M. B., Esselink, R. A. J., Bloem, B. R., Kuiperij, H. B., & Verbeek, M. M. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.09.003 · Cited by 84
Anxiety in Huntington’s Disease
Dale, M., & van Duijn, E. (2015) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.14100265 · Cited by 83
Familial aggregation of parkinsonism in progressive supranuclear palsy
Kaat, L. D., Boon, A. J. W., Azmani, A., Kamphorst, W., Breteler, M. M. B., Anar, B., Heutink, P., & Swieten, J. C. V. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a92bcc · Cited by 82
CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders
Herbert, M. K., Aerts, M. B., Beenes, M., Norgren, N., Esselink, R. A. J., Bloem, B. R., Kuiperij, H. B., & Verbeek, M. M. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00091 · Cited by 80
MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy
Vilariño‐Güell, C., Soto‐Ortolaza, A. I., Rajput, A. H., Mash, D. C., Papapetropoulos, S., Pahwa, R., Lyons, K. E., Uitti, R. J., Wszołek, Z. K., Dickson, D. W., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31820c30c1 · Cited by 79
Interrater agreement in the assessment of motor manifestations of Huntington's disease
Hogarth, P., Kayson, E., Kieburtz, K. D., Marder, K. S., Oakes, D., Rosas, H. D., Shoulson, I., Wexler, N. S., Young, A. B., Zhao, H., et al. (2004) · Movement Disorders · doi:10.1002/mds.20332 · Cited by 78
Jarvik, G. P., Larson, E. B., Goddard, K. A. B., Schellenberg, G. D., & Wijsman, E. M. (1996) · PubMed · Cited by 77
Neuroimaging in Huntington’s disease
Niccolini, F., & Politis, M. (2014) · World Journal of Radiology · doi:10.4329/wjr.v6.i6.301 · Cited by 77
The Neuropathology of FTD Associated With ALS
Mackenzie, I. R. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815c3486 · Cited by 70
Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study
Watson, R., O'Brien, J. T., Barber, R., & Blamire, A. M. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211002171 · Cited by 66
Clinical Phenomenology and Neuroimaging Correlates in ALS-FTD
Lomen‐Hoerth, C. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9636-x · Cited by 66
Definite multiple system atrophy in a German family
Wüllner, U., Schmitt, I., Kammal, M., Kretzschmar, H. A., & Neumann, M. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.158949 · Cited by 64
APOE genotype and survival in men and women with Alzheimer’s disease
Forno, G. D., Carson, K. A., Brookmeyer, R., Troncoso, J. C., Kawas, C. H., & Brandt, J. (2002) · Neurology · doi:10.1212/wnl.58.7.1045 · Cited by 64
Rüb, U., Hentschel, M., Stratmann, K., Brunt, E. R. P., Heinsen, H., Seidel, K., Bouzrou, M., Auburger, G. W. J., Paulson, H. L., Vonsattel, J., et al. (2013) · Brain Pathology · doi:10.1111/bpa.12115 · Cited by 64
Compta, Y., Valldeoriola, F., TOLOSA, E. S., Rey, M. J., Martí, M. J., & Valls‐Solé, J. (2007) · Movement Disorders · doi:10.1002/mds.21612 · Cited by 63
Symmetric corticobasal degeneration (S-CBD)
Hassan, A., Whitwell, J. L., Boeve, B. F., Jack, C. R., Parisi, J. E., Dickson, D. W., & Josephs, K. A. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.11.013 · Cited by 61
The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis
Cooper‐Knock, J., Kirby, J., Highley, J. R., & Shaw, P. J. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0342-1 · Cited by 60
Lebedev, A. V., Westman, E., Beyer, M. K., Kramberger, M. G., Aguilar, C., Pirtošek, Z., & Aarsland, D. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6768-z · Cited by 56
Early onset Huntington disease: a neuronal degeneration syndrome
Seneca, S., Fagnart, D., Keymolen, K., Lissens, W., Hasaerts, D., Debulpaep, S., Desprechins, B., Liebaers, I., & Meırleır, L. D. (2004) · European Journal of Pediatrics · doi:10.1007/s00431-004-1537-3 · Cited by 55
The impact of APOE on myocardial infarction, stroke, and dementia
Slooter, A. J. C., Cruts, M., Albert Hofman, D., Koudstaal, P. J., van der Kuip, D. A. M., de Ridder, M. A. J., Witteman, J. C. M., Breteler, M. M. B., Broeckhoven, C. V., & van Duijn, C. M. (2004) · Neurology · doi:10.1212/01.wnl.0000118302.66674.e1 · Cited by 55
Lee, C. S., Schulzer, M., de la Fuente‐Fernández, R., Mak, E., Kuramoto, L., Sossi, V., Ruth, T. J., Calne, D. B., & Stoessl, A. J. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1920 · Cited by 54
[18F]FDG-PET study in dementia with lewy bodies and alzheimer's disease
Okamura, N., Arai, H., Higuchi, M., Tashiro, M., Matsui, T., Hu, X.-S., Takeda, A., Itoh, M., & Sasaki, H. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)80005-1 · Cited by 54
Prion-Like Characteristics of Polyglutamine-Containing ProteinsPreprint
Pearce, M. M. P., & Kopito, R. R. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024257 · Cited by 53
Genome-wide estimate of the heritability of Multiple System Atrophy
Federoff, M., Price, T. R., Sailer, A., Scholz, S. W., Hernandez, D. G., Nicolas, A., Singleton, A., Nalls, M. A., & Houlden, H. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.11.005 · Cited by 52
Genetic players in multiple system atrophy: unfolding the nature of the beast
Stemberger, S., Scholz, S. W., Singleton, A., & Wenning, G. K. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.04.001 · Cited by 49
Henry, M. L., Wilson, S. M., Ogar, J. M., Sidhu, M., Rankin, K. P., Cattaruzza, T., Miller, B. L., Gorno‐Tempini, M. L., & Seeley, W. W. (2012) · Neurocase · doi:10.1080/13554794.2012.732089 · Cited by 48
Inappropriate sexual behaviour in a case of ALS and FTD: Successful treatment with sertraline
Anneser, J. M. H., Jox, R. J., & Borasio, G. D. (2007) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960601073543 · Cited by 47
Obsessive-compulsive disorders in Pick's disease
Tonkonogy, J. M., Smith, T. W., & Barreira, P. J. (1994) · Journal of Neuropsychiatry · doi:10.1176/jnp.6.2.176 · Cited by 44
Evidence-based Evaluation of Magnetic Resonance Imaging as a Diagnostic Tool in Dementia Workup
Wahlund, L., Almkvist, O., Blennow, K., Engedahl, K., Johansson, A., Waldemar, G., & Wolf, H. (2005) · Topics in Magnetic Resonance Imaging · doi:10.1097/01.rmr.0000245463.36148.12 · Cited by 44
Influence of the amyloid precursor protein locus on dementia in Down syndrome
Margallo‐Lana, M. L., Morris, C. M., GIBSON, A. M., Tan, A. L., Kay, D. W. K., Tyrer, S. P., Moore, B. P., & Ballard, C. G. (2004) · Neurology · doi:10.1212/01.wnl.0000129275.13169.be · Cited by 43
Hardware complications in deep brain stimulation: Electrode impedance and loss of clinical benefit
Guridi, J., Rodríguez‐Oroz, M., Alegre, M., et al. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.03.014 · Cited by 42
Familial Aggregation of Dementia With Lewy Bodies
Nervi, A., Reitz, C., Tang, M., Santana, V., Piriz, A. L., Reyes, D., Lantigua, R., Medrano, M. Z., Jiménez‐Velázquez, I. Z., Lee, J. H., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.319 · Cited by 42
Pathology in Primary Progressive Aphasia Syndromes
Harris, J., & Jones, M. S. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0466-4 · Cited by 41
Lee, J., Kim, T.-H., Mun, C., Kim, T., & Han, Y.-H. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7785-5 · Cited by 38
Genetics of Frontotemporal Lobar Degeneration
Galimberti, D., & Scarpini, E. A. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00052 · Cited by 37
A Clinical Guide to Frontotemporal Dementias
Ljubenkov, P. A., & Miller, B. L. (2016) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20160018 · Cited by 37
Tau genotype: No effect on onset, symptom severity, or survival in progressive supranuclear palsy
Litvan, I., Baker, M. C., & Hutton, M. L. (2001) · Neurology · doi:10.1212/wnl.57.1.138 · Cited by 36
Behavioural symptoms in progressive supranuclear palsy and frontotemporal dementia
Bak, T. H., Crawford, L. M., Berrios, G. E., et al. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.157974 · Cited by 35
FULHAM, M. J., Dubinsky, R., Polinsky, R. J., et al. (1991) · Clinical Autonomic Research · doi:10.1007/bf01826055 · Cited by 34
Familial dementia with Lewy bodies: Clinicopathologic analysis of two kindreds
Galvin, J. E., Lee, S. L., Perry, A., Havlioglu, N., McKeel, D. W., & Morris, J. C. (2002) · Neurology · doi:10.1212/wnl.59.7.1079 · Cited by 34
Cusin, C., Franco, F. B., Fernandez-Robles, C. G., DuBois, C. M., & WELCH, C. A. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.01.015 · Cited by 33
Family history of dementia is a risk factor for Lewy body disease
Woodruff, B. K., Graff‐Radford, N. R., Ferman, T. J., Dickson, D. W., DeLucia, M. W., Crook, J. E., Arvanitakis, Z., Brassler, S., Waters, C., Barker, W., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000219812.20616.b3 · Cited by 31
Deep brain stimulation for the treatment of Parkinson’s disease: efficacy and safety
Bronstein, J. M., Pouratian, Thakkar, & Kim (2012) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s25750 · Cited by 27
Non-Picks frontotemporal dementia imitating schizophrenia in a 22-year-old man
Stone, J., Griffiths, T. D., Rastogi, S., Perry, R. H., & Cleland, P. G. (2003) · Journal of Neurology · doi:10.1007/s00415-003-0989-0 · Cited by 25
Is FDG‐PET a useful tool in clinical practice for diagnosing corticobasal ganglionic degeneration?
Coulier, I. M. F., de Vries, J. J., & Leenders, K. L. (2003) · Movement Disorders · doi:10.1002/mds.10498 · Cited by 23
Chiba, Y., Fujishiro, H., Ota, K., Kasanuki, K., Arai, H., Hirayasu, Y., Sato, K., & Iseki, E. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4144 · Cited by 20
Pure akinesia as initial presentation of PSP: A clinicopathological study
Facheris, M., Maniak, S., Scaravilli, F., Schüle, B., Klein, C., & Pramstaller, P. P. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.11.004 · Cited by 20
Sha, S. J., & Rabinovici, G. D. (2016) · Wiley eBooks · doi:10.1002/9781118797662.ch3 · Cited by 5
Lippa, C. F., & Possin, K. L. (2016) · Wiley eBooks · doi:10.1002/9781118797662.ch6 · Cited by 1
Research works printed but not linked: 9
- 10.1212/WNL.48.2.384 · doi:10.1212/wnl.48.2.384
- 2009, Teaching neuroimages: “Penguin” or “hummingbird” sign and midbrain atrophy in progressive supranuclear palsy, Neurology, 72, e81, 10.1212/WNL.0b013e3181a2e815 · doi:10.1212/wnl.0b013e3181a2e815
- 10.1001/archneur.55.8.1099 · doi:10.1001/archneur.55.8.1099
- 10.1016/j.jalz.2011.03.005 · DOI · Paper page
- 1981, A life table for onset of Huntington’s chorea, Ann Hum Genet, 45, 375, 10.1111/j.1469-1809.1981.tb00351.x · doi:10.1111/j.1469-1809.1981.tb00351.x
- 2015, Imaging dementia-evidence for amyloid scanning (IDEAS)—A national study to evaluate the clinical utility of amyloid PET, Alzheimers Dement (Amst), 11, P263, 10.1016/j.jalz.2015.07.341 · doi:10.1016/j.jalz.2015.07.341
- 10.1176/appi.ajgp.10.1.89 · doi:10.1176/appi.ajgp.10.1.89
- 10.1097/01.wnf.0000183240.47960.f0 · doi:10.1097/01.wnf.0000183240.47960.f0
- 2012, Cognitive stimulation to improve cognitive functioning in people with dementia, Cochrane Database Syst Rev, 2, CD005562
Cited by
Hallmarks of neurodegenerative diseases
Wilson, D. M., Cookson, M. R., Van Den Bosch, L., Zetterberg, H., Holtzman, D. M., & Dewachter, I. (2023) · Cell · doi:10.1016/j.cell.2022.12.032 · Cited by 1,789
Brain charts for the human lifespan
Bethlehem, R. A. I., Seidlitz, J., White, S. R., Vogel, J. W., Anderson, K. M., Adamson, C., Adler, S., Alexopoulos, G. S., Anagnostou, E., Areces-Gonzalez, A., et al. (2022) · Nature · doi:10.1038/s41586-022-04554-y · Cited by 1,794
Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease
Da Mesquita, S., Louveau, A., Vaccari, A., Smirnov, I., Cornelison, R. C., Kingsmore, K. M., Contarino, C., Onengut-Gumuscu, S., Farber, E., Raper, D., et al. (2018) · Nature · doi:10.1038/s41586-018-0368-8 · Cited by 1,445
Simpson, D. S. A., & Oliver, P. L. (2020) · Antioxidants · doi:10.3390/antiox9080743 · Cited by 1,044
“Due to their debilitating nature and lack of any effective treatment, neurodegenerative diseases are a growing economic burden to society [1].”
BackgroundClinical applications of stem cell-derived exosomes
Tan, F., Li, X., Wang, Z., Li, J., Shahzad, K., & Zheng, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01704-0 · Cited by 708
Metadata
- Authors
- Erkkinen, M. G., Kim, M.-O., & Geschwind, M. D.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2017-07-17
- Volume
- 10
- Issue
- 4
- Pages
- a033118
- ISSN
- 1943-0264 (ISSN-L)
- OpenAlex
- W2734706909
- Cited by
- 1,124
- References
- 334
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.